Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan - Wikidata - wikimedia - TriplyDB

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan

http://www.wikidata.org/entity/Q34947842

about

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib ALK-rearrangements and testing methods in non-small cell lung cancer: a review Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR.Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.Clinicopathological characteristics of patients with non-small-cell lung cancer who harbor EML4-ALK fusion gene: a meta-analysis Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer Clinical Implications of Variant ALK FISH Rearrangement Patterns.Anaplastic lymphoma kinase protein expression predicts micrometastases and prognosis for patients with hepatocellular carcinoma Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer.ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma.Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancer First-line treatment of advanced ALK-positive non-small-cell lung cancer.The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients.Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer.Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer.Prognostic and predictive biomarkers in lung cancer. A review.Anaplastic lymphoma kinase: Role in cancer and therapy perspective.Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.Proteogenomics for understanding oncology: recent advances and future prospects.A mass spectrometry assay to simultaneously analyze ROS1 and RET fusion gene expression in non-small-cell lung cancer.Thyroid metastasis from lung adenocarcinoma with EML4-ALK rearrangement Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer.Diagnostic accuracy of PCR for detecting ALK gene rearrangement in NSCLC patients: A systematic review and meta-analysis.Economic analysis of ALK testing and crizotinib therapy for advanced non-small-cell lung cancer.Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.RETRACTED: Identification of circulating tumor cells with EML4-ALK translocation using fluorescence in situ hybridization in advanced ALK-positive patients with lung cancer.

P2860

Q28083386-733E7D8A-83E7-4434-B48A-0D3F3BC40A03 Q28083711-F0F565C1-BB89-411C-919A-6AF5AEEF744D Q33776835-D66D84BA-5F37-4A2B-8076-6FB72C649BE4 Q33844713-0D4FF5B6-BB72-4DB4-8CA6-F7E5F291AE48 Q34231928-D27FEFBE-E300-4326-ADA9-9880D31588F6 Q35005185-07EAB2B6-71D5-4BA8-A0F4-CA97806DD8C3 Q35113209-BABE7B03-1738-4385-B1EA-09C559ADB3EE Q35192525-0410A189-6227-4D52-8982-3D07D3D7B852 Q35202837-EF5B1AC9-A719-44ED-88BD-981F6CB3CCA4 Q36096398-924D8364-48BB-4F82-A01C-0DE8F8478580 Q36250969-883D3CC0-46BE-40EA-997B-3CB061A57949 Q36502649-E8C1C61C-7DEC-4A52-A19E-361DE34DC655 Q36860098-CCFBED63-261B-4A4C-AB88-F38AC2B6EEAA Q36866859-4B339BB1-75B6-49AE-A5BE-FCFDD91788B4 Q36948934-B094B719-DB61-4F46-99AB-92E050843293 Q37480093-05E6CB8C-CC4F-4617-9F04-7E5C42945FB5 Q37566842-6CA7FC1B-DD17-411C-B6F7-4EB1D2AE3DDB Q37601901-426A3B00-EA1E-4076-87E5-ED39AAAB516C Q37630493-0EAEA41A-EDAB-43B4-910B-C66C7D48D2AF Q37633877-F526CFC7-2F6A-45DF-89BB-29FBDE786342 Q38178187-8A64F8E0-C550-4854-AF7C-00FEBC94641B Q38623421-CDAA0D8A-C717-4AD5-99F7-F6A85F4160C1 Q38631019-4604BCF9-9B70-4D3F-897F-6DFE5771F42F Q38649524-307C7921-D89B-469C-A03F-4F043C19A6CC Q38677257-2B8D939A-1A03-4E23-B008-B4B5BA41C1F5 Q38941499-AC710E89-BDEE-41EF-AF1E-71677386403E Q42264459-CF8BFABB-CFEB-4732-B400-F5C2851768CA Q45907759-4C9426D8-111C-4F7B-8C03-C1C4B3DE2B56 Q47103708-8CB63ABE-0DCE-4507-A9B0-E03027B9CF5D Q50632474-3E1475E0-A69E-407F-B60A-ECB1DBCDE0B8 Q50675747-B10404B2-CCC3-4653-9FCD-09A273755CFB Q53656515-C1C191D6-70B5-4F65-A84E-065119AE85E7 Q54227226-872C45F5-9992-4AAC-83CC-D88D0B7599C7 Q54977996-026C591B-654B-4329-8B07-532F56968C82

P2860

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan

http://www.wikidata.org/entity/Q34947842

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@ast

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@en

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@nl

type

label

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@ast

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@en

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@nl

prefLabel

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@ast

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@en

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@nl

P1433

Q34947842-FA56E24D-9E12-4388-A435-E810B4357AB0

P1476

Q34947842-7651DF1F-44DB-4D48-8A3E-7CDF17512DB9

P2093

Q34947842-1118976D-E66E-4119-BF93-23B3D887CCC6

Q34947842-3020640C-554F-469D-B7FE-BC8B787C229D

Q34947842-4798D2BD-4C2D-4530-8FFE-BB87D07C4944

Q34947842-563FE6E4-8D6D-466B-977B-44CD81E10CE1

Q34947842-89BA59CD-C2F1-42F5-A1E3-D6231EF07606

Q34947842-95D8FE00-F955-4EE9-AA53-237819DB7C6B

Q34947842-B9D79454-9BF3-4DDE-8D24-72A400E8B2D0

Q34947842-C1E7B632-DADC-41A8-9B52-A1C8EB138782

Q34947842-C2363371-7B3A-4A56-A5BE-B670DB0A56A0

Q34947842-C5F8AFDD-AB79-455A-B713-C45446EEE166

P2860

Q34947842-04EE52F2-8742-40B2-863D-58CE55167298

Q34947842-0ACE1CBE-75D3-4314-9197-E2D1F5BE5B2A

Q34947842-0C4C0F1E-0D44-4C91-96B9-902C1CD8F796

Q34947842-1546B331-6D16-4B39-938C-F8891B9632D5

Q34947842-17BFC77E-447B-4337-99D4-C48EE777C77D

Q34947842-190253D8-33CD-4C4A-8EC6-9029A2B18EC6

Q34947842-2B66E443-BD3F-4C3E-8EC7-DC4CCDDD790F

Q34947842-30A35422-AE66-45B0-8914-1C56C14EFEB6

Q34947842-3484D922-7754-4EAF-AFE9-F78FA95CEF8F

Q34947842-3B332135-84E8-4815-8262-EF81B809F4C3

P304

Q34947842-AB7DCC24-22A5-49EE-9D76-343B220622B9

P31

Q34947842-C88EA1F2-4EC1-4500-85DE-86DB11BE889C

P356

Q34947842-5FF9AB1B-45BA-453B-9CA6-6D67ED1F4C37

P407

Q34947842-EFEDA3D1-0757-44EA-A4DC-FAEB0666F905

P433

Q34947842-D66E19B8-49CD-4335-A964-050C581FD845

P478

Q34947842-99AD46EC-89D2-4B75-A5DD-94B241F5BBFA

P50

Q34947842-C7B4E9A1-0E10-48A6-8A6A-F8195A158357

P577

Q34947842-445CFC6C-5EAB-4E97-AAC9-3F0B9D954315

P5875

Q34947842-B7EBE2E7-5510-470F-8385-7B3290B849C8

P698

Q34947842-40612F57-9EDF-47D7-8A00-D4BD5365EDC7

P932

Q34947842-A403A1AC-27AF-46AB-90F0-93D7136EA4E3

P356

JOURNAL.PONE.0070839

P1433

P1476

Comparison of IHC, FISH and RT ...... lung cancer patients in Taiwan

@en

P2093

Chi-Liang Wang

http://www.w3.org/2001/XMLSchema#string

Hui-Ping Liu

http://www.w3.org/2001/XMLSchema#string

Il-Chi Chang

http://www.w3.org/2001/XMLSchema#string

Li-Hui Chou

http://www.w3.org/2001/XMLSchema#string

Shiu-Feng Huang

http://www.w3.org/2001/XMLSchema#string

Tai-Di Chen

http://www.w3.org/2001/XMLSchema#string

Tzu-Hua Wu

http://www.w3.org/2001/XMLSchema#string

Ya-Ting Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Cheng Wu

http://www.w3.org/2001/XMLSchema#string

Yi-Rong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Anaplastic lymphoma kinase: signalling in development and disease

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

P304

e70839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0070839

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255959424

http://www.w3.org/2001/XMLSchema#string

P698

23951022

http://www.w3.org/2001/XMLSchema#string

P932

3737393

http://www.w3.org/2001/XMLSchema#string